electroCore to Present at the Market Movers Investor Summit on May 5, 2026
electroCore, Inc., a Nasdaq-listed bioelectronic medicine company specializing in non-invasive neuromodulation technologies for chronic pain and wellness, announced its participation in the Market Movers Investor Summit on May 5, 2026. Interim President and CFO Joshua Lev will present and meet with investors, providing an opportunity to showcase th…